Globeflex Capital’s Ironwood Pharmaceuticals IRWD Stock Holding History

Globeflex Capital’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09M	Hold	259,809	–	–	0.14%	169
2026 Q1	$912K	Buy	+259,809	New	+$1.06M	0.14%	166
2023 Q1	–	Sell	-121,452	Closed	-$1.5M	–	493
2022 Q4	$1.5M	Sell	121,452 -35,174	-22%	-$399K	0.19%	129
2022 Q3	$1.62M	Buy	156,626 +47,386	+43%	+$537K	0.28%	106
2022 Q2	$1.26M	Hold	109,240	–	–	0.31%	89
2022 Q1	$1.37M	Hold	109,240	–	–	0.28%	97
2021 Q4	$1.27M	Hold	109,240	–	–	0.26%	117
2021 Q3	$1.43M	Buy	109,240 +37,625	+53%	+$486K	0.31%	86
2021 Q2	$922K	Buy	71,615 +121	+0.2%	+$1.39K	0.17%	203
2021 Q1	$799K	Hold	71,494	–	–	0.15%	226
2020 Q4	$814K	Buy	71,494 +17,144	+32%	+$188K	0.17%	196
2020 Q3	$489K	Hold	54,350	–	–	0.13%	255
2020 Q2	$561K	Hold	54,350	–	–	0.14%	246
2020 Q1	$548K	Buy	54,350 +10,534	+24%	+$124K	0.17%	210
2019 Q4	$583K	Buy	+43,816	New	+$483K	0.11%	292
2015 Q2	–	Sell	-92,367	Closed	-$1.24M	–	541
2015 Q1	$1.24M	Buy	+92,367	New	+$1.21M	0.24%	166

Other funds holding IRWD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Globeflex Capital's IRWD Position: Q2 2026 in Review

Globeflex Capital held its Ironwood Pharmaceuticals (IRWD) position steady in Q2 2026 at 259,809 shares worth $1.09M. The position accounts for 0.14% of the portfolio, ranked #169.

Globeflex Capital first reported a position in IRWD in Q1 2015 and has held it in 16 quarters since. The position peaked at $1.62M in Q3 2022. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

Globeflex Capital held 259,809 shares of Ironwood Pharmaceuticals worth $1.09M as of Q2 2026.
Globeflex Capital left its Ironwood Pharmaceuticals share count unchanged in Q2 2026.
Ironwood Pharmaceuticals made up 0.14% of Globeflex Capital's portfolio in Q2 2026, its #169 holding.
Globeflex Capital first reported a position in Ironwood Pharmaceuticals in Q1 2015 and has held it in 16 quarters since.
Globeflex Capital's Ironwood Pharmaceuticals position peaked at $1.62M in Q3 2022.
212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.